• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[乳腺原位癌]

[Carcinoma in situ of the breast].

作者信息

Laenkholm Anne-Vibeke, Hoffmann Jack, Rank Fritz E

机构信息

Odense Universitetshospital, Afdeling for Klinisk Patologi, Hørsholm Sygehus, Brystkirurgisk Klinik.

出版信息

Ugeskr Laeger. 2007 Sep 10;169(37):3087-90.

PMID:17877955
Abstract

Ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS) represent a proliferation of malignant epithelial cells within the ducts of the breast without invasion through the basement membrane. It is assumed that all invasive carcinomas of the breast are preceded by DCIS or LCIS. However, it is not known what proportion of DCIS or LCIS--if left untreated--will progress to invasive carcinoma. Standard treatment for DCIS is breast-conserving surgery with free margins and radiation therapy. LCIS is usually treated by observation alone.

摘要

导管原位癌(DCIS)和小叶原位癌(LCIS)表现为乳腺导管内恶性上皮细胞的增殖,且未突破基底膜发生浸润。一般认为,所有乳腺浸润性癌之前都有DCIS或LCIS。然而,尚不清楚DCIS或LCIS(若不治疗)会进展为浸润性癌的比例是多少。DCIS的标准治疗方法是行切缘阴性的保乳手术及放射治疗。LCIS通常仅通过观察进行治疗。

相似文献

1
[Carcinoma in situ of the breast].[乳腺原位癌]
Ugeskr Laeger. 2007 Sep 10;169(37):3087-90.
2
Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.同时存在的增殖性高危病变对接受保乳治疗的导管原位癌患者同侧乳腺癌复发风险及对侧乳腺癌发生风险的影响。
Cancer. 2006 Jan 1;106(1):42-50. doi: 10.1002/cncr.21571.
3
[Radiotherapy of in situ carcinoma of the breast. EORTC Breast Group].[乳腺癌原位癌的放射治疗。欧洲癌症研究与治疗组织乳腺癌研究组]
Praxis (Bern 1994). 1998 Apr 8;87(15):520-3.
4
Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ.国家外科辅助乳腺项目(NSABP)B-17方案的病理结果。关于小叶原位癌的五年观察。
Cancer. 1996 Oct 1;78(7):1403-16. doi: 10.1002/(SICI)1097-0142(19961001)78:7<1403::AID-CNCR6>3.0.CO;2-L.
5
[Therapeutic problems posed by sub-clinical breast cancers].[亚临床乳腺癌带来的治疗问题]
Contracept Fertil Sex. 1999 Apr;27(4):298-305.
6
The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.小叶原位癌合并浸润性乳腺癌对接受保乳治疗的早期乳腺癌患者局部复发率的影响。
Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):365-71. doi: 10.1016/j.ijrobp.2006.05.070.
7
[Surgical therapy strategies in carcinoma in situ of the breast].[乳腺原位癌的手术治疗策略]
Praxis (Bern 1994). 1998 Apr 8;87(15):516-9.
8
[Breast cancer: apropos of "in situ"].[乳腺癌:关于“原位”]
Rev Med Brux. 1995 Jul-Aug;16(4):231-4.
9
Bilateral and multifocal breast carcinoma. A clinical and autopsy study with special emphasis on carcinoma in situ.双侧及多灶性乳腺癌。一项特别关注原位癌的临床与尸检研究。
Eur J Surg Oncol. 1991 Feb;17(1):20-9.
10
The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast.乳腺小叶原位癌和不典型小叶增生的意义。
Ann Surg Oncol. 2012 Dec;19(13):4124-8. doi: 10.1245/s10434-012-2538-5. Epub 2012 Jul 31.